Also trades as: THYROCARE.NS (NSE) · $vol 4M
THYROCARE.BO BSE
Thyrocare Technologies Limited
1W: -5.7%
1M: -9.3%
3M: -3.4%
YTD: +31.5%
1Y: -61.0%
3Y: -2.9%
5Y: -56.0%
₹536.00 ($5.57)
+1.65 (+0.31%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$7.5B
+7.9% ▲
5Y CAGR: +6.5%
Total Liabilities
$1.6B
+10.6% ▲
5Y CAGR: +6.3%
Shareholders Equity
$5.9B
+7.1% ▲
5Y CAGR: +6.5%
Cash & Investments
$2.3B
+20.6% ▲
5Y CAGR: +14.5%
Total Debt
$507M
+105.4% ▲
5Y CAGR: +43.0%
Net Debt
$124M
+76.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $136M | $178M | $94M | $177M | $383M |
| Short-Term Investments | $1.3B | $1.3B | $1.7B | $1.7B | $1.9B |
| Cash & ST Investments | $1.4B | $1.5B | $1.8B | $1.9B | $2.3B |
| Net Receivables | $945M | $857M | $442M | $822M | $739M |
| Inventory | $344M | $302M | $475M | $538M | $485M |
| Other Current Assets | $10M | $37M | $100K | $64M | $188M |
| Total Current Assets | $2.7B | $2.7B | $2.8B | $3.4B | $3.7B |
| Property, Plant & Equip. | $1.9B | $1.9B | $2.0B | $2.0B | $2.1B |
| Goodwill & Intangibles | $1.0B | $1.0B | $1.0B | $1.1B | $1.1B |
| Long-Term Investments | $209M | $221M | $256M | $249M | $251M |
| Other Non-Current Assets | $223M | $299M | $313M | $102M | $137M |
| Total Non-Current Assets | $3.4B | $3.6B | $3.7B | $3.6B | $3.7B |
| Total Assets | $6.1B | $6.3B | $6.4B | $6.9B | $7.5B |
| — Liabilities — | |||||
| Accounts Payable | $165M | $240M | $401M | $762M | $654M |
| Short-Term Debt | $50M | $0 | $107M | $0 | $0 |
| Deferred Revenue | $93M | $366M | $62M | $0 | $0 |
| Other Current Liabilities | $132M | -$45M | $193M | $355M | $306M |
| Total Current Liabilities | $645M | $771M | $905M | $1.2B | $1.1B |
| Long-Term Debt | $0 | $0 | $109M | $0 | $0 |
| Other Non-Current Liab. | $3M | $33M | $31M | $69M | $121M |
| Total Non-Current Liabilities | $166M | $204M | $258M | $239M | $513M |
| Total Liabilities | $811M | $975M | $1.2B | $1.5B | $1.6B |
| — Equity — | |||||
| Common Stock | $529M | $529M | $530M | $530M | $1.6B |
| Retained Earnings | $3.6B | $3.4B | $3.2B | $3.1B | $1.3B |
| Accumulated OCI | $453M | $653M | $804M | $462M | $2.9B |
| Total Stockholders Equity | $5.3B | $5.3B | $5.3B | $5.5B | $5.9B |
| Total Liabilities & Equity | $6.1B | $6.3B | $6.4B | $6.9B | $7.5B |
| — Key Metrics — | |||||
| Total Debt | $207M | $233M | $423M | $247M | $507M |
| Net Debt | $71M | $55M | $330M | $70M | $124M |
| Total Investments | $1.5B | $1.6B | $1.9B | $2.0B | $2.2B |